Article

Anecortave acetate program terminated, says Alcon

Alcon announced the termination of the development program designed to evaluate the benefit of anecorative acetate treatment on the risk for developing choroidal neovascularization secondary to age-related macular degeneration.

Heunenberg, Switzerland-Alcon announced the termination of the development program designed to evaluate the benefit of anecorative acetate treatment on the risk for developing choroidal neovascularization secondary to age-related macular degeneration.

The decision followed an interim analysis of studies CO-02-60 A and B, performed after 2,546 patients completed the 24-month time point. It was found that anecorative acetate showed no effect on the primary or secondary endpoints.

The company also terminated two smaller studies with identical designs, being conducted in Asia, CO-04-30 and C-05-34.

Anecorative acetate is still being studied by the company as an anterior juxtascleral depot to reduce IOP in patients with open-angle glaucoma.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.